E. Rollón

Prognostic impact of neoadjuvant aglepristone treatment in clinicopathological parameters of progesterone receptor‐positive canine mammary carcinomas

S. Guil-Luna, Y. Millán, J. M. Mulas, 2017, Veterinary and comparative oncology.

Immunohistochemical Characterization of Hemangiopericytomas and Other Spindle Cell Tumors in the Dog

J. Pérez, J. M. Mulas, L. Carrasco, 1996, Veterinary pathology.

Perineal leiomyoma expressing steroidal hormone receptors in a queen

C. Reymundo, Y. Millán, J. Martín de las Mulas, 2002, Veterinary Record.

Effects of aglepristone, a progesterone receptor antagonist, in a dog with a vaginal fibroma.

Y. Millán, J. M. de las Mulas, E. Rollón, 2007, The Journal of small animal practice.

Aglepristone decreases proliferation in progesterone receptor-positive canine mammary carcinomas.

F. Guscetti, S. Guil-Luna, Y. Millán, 2011, Journal of veterinary internal medicine.

Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma

J. Stenvang, N. Brünner, S. Guil-Luna, 2014, BMC Veterinary Research.

Apoptosis and mitosis in tumours of the skin and subcutaneous tissues of the dog.

Y. Millán, A. Espinosa de los Monteros, M. J. Bautista, 1999, Research in veterinary science.